Sunbird Bio Appoints Richard Batrla, M.D., Ph.D., MBA as Chief Medical Officer

CAMBRIDGE, Mass. & SINGAPORE–(BUSINESS WIRE)–Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the appointment of Richard Batrla, M.D., Ph.D., MBA as chief medical officer. “There couldn’t be a better time to welcome Richard to the team as we embark on a new year and anticipate several exciting milestones ahead,” said John McDonough, executive chairman and CE
Top